In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome

被引:115
作者
Flores-Figueroa, E
Gutiérrez-Espíndola, G
Montesinos, JJ
Arana-Trejo, RM
Mayani, H
机构
[1] IMSS, Oncol Res Unit, Oncol Hosp, Natl Med Ctr, Mexico City 06720, DF, Mexico
[2] IMSS, Dept Hematol, Bernardo Sepulveda Hosp, Natl Med Ctr, Mexico City, DF, Mexico
[3] Mexico City Gen Hosp, Dept Genet, Mexico City, DF, Mexico
关键词
bone marrow; cytokines; fibroblasts; hematopoiesis; macrophages; myelodysplasia;
D O I
10.1016/S0145-2126(01)00193-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In vitro studies on the functional integrity of the hematopoietic microenvironment in myelodysplasia have been controversial. Although some of them suggest that such a microenvironment is functionally normal, there is increasing evidence indicating that there are alterations in the function of microenvironment (adherent) cell layers from myelodysplastic syndromes (MDS) marrow. Adherent cell layers developed in vitro, however, consist of a mixture of different cell types-mostly fibroblasts and macrophages-thus, it is not clear which cell type(s) is(are) functionally abnormal in this disorder. In order to address this issue, in the present study, we first assessed some functional properties of MDS-derived adherent cell layers, as a whole, and then we analyzed those same functional properties after separating these cells into two different Populations: a fibroblast-enriched cell layer and a macrophage-enriched cell layer. When whole adherent layers from MDS patients were analyzed, no significant differences were observed, as compared to their normal Counterparts, in terms of morphology and total cell number. A major difference, however, was observed when analyzing the production of the cytokines interleukin-6 (IL-6) and tumor necrosis factor (TNF-alpha), Indeed, adherent layers from MDS patients produced higher levels of these cytokines (2- and 22-fold, respectively), as compared to normal layers. When fibroblast- and macrophage-enriched cell layers were analyzed, a higher apoptotic index was observed in those derived from MDS marrow (4% of TUNEL-positive cells in normal fibroblast layers versus 27% in MDS-derived fibroblast layers; 7% of TUNEL-positive cells in normal macrophage layers versus 24% in MDS macrophage layers). Macrophages from MDS marrow produced significantly higher levels of TNF-alpha (nine-fold) than their normal counterparts. MDS-derived fibroblasts, on the other hand, produced higher levels of IL-6 (nine-fold), as compared to normal fibroblasts. Surprisingly, whereas normal fibroblasts showed a discrete production of TNF-alpha, we found a very high production of this cytokine in cultures of fibroblasts from MDS patients. In summary, in the present Study we have demonstrated that, at least in vitro, both fibroblasts and macrophages from MDS bone marrow (BM) are functionally abnormal. Such abnormalities include an increased apoptotic index, as well as a high production of both IL-6 and TNF-alpha. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:677 / 686
页数:10
相关论文
共 32 条
[1]   Bone marrow stroma from refractory anemia of myelodysplastic syndrome is defective in its ability to support normal CD34-positive cell proliferation and differentiation in vitro [J].
Aizawa, S ;
Nakano, M ;
Iwase, O ;
Yaguchi, M ;
Hiramoto, M ;
Hoshi, H ;
Nabeshima, R ;
Shima, D ;
Handa, H ;
Toyama, K .
LEUKEMIA RESEARCH, 1999, 23 (03) :239-246
[2]  
BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
[3]  
CASTROMALASPINA H, 1980, BLOOD, V56, P289
[4]   FUNCTIONAL-STUDIES OF BONE-MARROW HEMATOPOIETIC AND STROMAL CELLS IN THE MYELODYSPLASTIC SYNDROME (MDS) [J].
COUTINHO, LH ;
GEARY, CG ;
CHANG, J ;
HARRISON, C ;
TESTA, NG .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (01) :16-25
[5]  
DAN K, 1993, ACTA HAEMATOL-BASEL, V89, P113
[6]   Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome [J].
Deeg, HJ ;
Beckham, C ;
Loken, MR ;
Bryant, E ;
Lesnikova, M ;
Shulman, HM ;
Gooley, T .
LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) :405-+
[7]   Hematopoietic progenitor cells from patients with myelodysplastic syndromes:: in vitro colony growth and long-term proliferation [J].
Flores-Figueroa, E ;
Gutiérrez-Espindola, G ;
Guerrero-Rivera, S ;
Pizzuto-Chavez, J ;
Mayani, H .
LEUKEMIA RESEARCH, 1999, 23 (04) :385-394
[8]   A role for tumour necrosis factor-α, Fas and Fas-ligand in marrow failure associated with myelodysplastic syndrome [J].
Gersuk, GR ;
Beckham, C ;
Loken, MR ;
Kiener, P ;
Anderson, JE ;
Farrand, A ;
Troutt, AB ;
Ledbetter, JA ;
Deeg, HJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) :176-188
[9]  
GLINSMANNGIBSON B, 1994, LEUKEMIA, V8, P827
[10]   PRELEUKEMIC SYNDROME - CORRELATION OF INVITRO PARAMETERS OF GRANULOPOIESIS WITH CLINICAL-FEATURES [J].
GREENBERG, PL ;
MARA, B .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (06) :951-958